Out Fox The $treet

Summary Seeking strong cash flow from monetizing patents. Conducting numerous licensing campaigns providing catalysts for the stock. The patent stocks are currently unloved after big losses during the last couple of years. A few years back, the patent investment segment was one of the hottest sectors in the stock market. Now the segment has gone mostly flat with few big patent victories and declining stock prices. The momentum investor looking for the big gains moved into the hot social media and biotech stocks. Typically, once investors lose interest in a sector is the best time to become interested. Read the full article at Seeking Alpha. Disclosure: No positions mentioned. Please review the disclaimer page for more details. 

With patent stocks being all the rage in 2012, the recent deal for Spherix ( SPEX ) to purchase a bunch of patents created by the Harris Corporation has basically gone unnoticed. Possibly because the company was mostly unknown prior to this pending deal or possibly the leading patent stocks of VirnetX Holding ( VHC ) and Vringo ( VRNG ) have struggled this year thereby lessening investor appetite. The recent news on quickly closing another patent deal with Rockstar has again jumpstarted the stock after the original news had faded sending the stock to new lows. Spherix is in the process of launching a broad IP monetization initiative adding to its drug development and patenting expertise. The company has identified a couple of undervalued IP assets that it plans to generate value for shareholders through licensing and enforcement. Read the full article at Seeking Alpha. Disclosure: No positions mentioned. Please review the disclaimer page for more details.  ...